Product information
From Health Canada
Current status:
Marketed
Current status date:
2017-04-24
Original market date: See footnote 1
2014-02-12
Product name:
DRY EYE TEARS
DIN:
02389886 Electronic product monograph is not available
Company:
TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada
M1B 2K9
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
52:13.00* See footnote6
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.
Active ingredient group (AIG) number:See footnote5
0233242001
Active ingredient(s) | Strength |
---|---|
GLYCERINE | 0.2 % / W/V |
HYPROMELLOSE | 0.2 % / W/V |